Arexvy vial kits
Ended Awarded
- Contract number
- SPE2DB25FGXSZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,440
Award facts
- Contract value 100% obligated
- $1,440.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,440.44 to AmerisourceBergen Drug Corp for AREXVY vial kits on September 3, 2025, with an ultimate completion date of September 4, 2025. AREXVY is a prescription medication used in the treatment of systemic sclerosis. This firm fixed price delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999.999 billion through December 2026. The award was competitively procured with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. The company's extensive portfolio with the Defense Logistics Agency demonstrates its capability to supply a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order exemplifies the operational flexibility of the company's prime vendor relationship, enabling rapid fulfillment of specific medical supply needs for the Defense Health Agency and other federal healthcare customers.
Quick answers
Who was awarded contract SPE2DB25FGXSZ?
SPE2DB25FGXSZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FGXSZ worth?
The government has obligated $1,440 on SPE2DB25FGXSZ.
Is contract SPE2DB25FGXSZ an order under another contract?
Yes. SPE2DB25FGXSZ is a delivery order under SPE2DB24D2213, an indefinite delivery contract.
Was contract SPE2DB25FGXSZ competed?
The extent of competition for SPE2DB25FGXSZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award